Falvella FS - Search Results

1

Seizures in patients with chronic hepatitis C treated with NS3/4A protease inhibitors: does pharmacological interaction play a role?

Milazzo L, Falvella FS, Magni C, Gervasoni C, Peri AM, Cattaneo D, Antinori S, Vidale S. Milazzo L, et al. Among authors: falvella fs. Pharmacology. 2013;92(5-6):235-7. doi: 10.1159/000355836. Epub 2013 Oct 31. Pharmacology. 2013. PMID: 24192929

2

Levofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics.

Gervasoni C, Cattaneo D, Falvella FS, Vitiello P, Cheli S, Milazzo L, Clementi E, Riva A. Gervasoni C, et al. Among authors: falvella fs. Eur J Clin Pharmacol. 2013 Aug;69(8):1611-3. doi: 10.1007/s00228-013-1515-7. Epub 2013 Apr 25. Eur J Clin Pharmacol. 2013. PMID: 23616064 No abstract available.

3

SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir.

Milazzo L, Peri AM, Mazzali C, Magni C, Calvi E, De Nicolò A, Clementi E, Cheli S, D'Avolio A, Antinori S, Falvella FS. Milazzo L, et al. Among authors: falvella fs. J Antimicrob Chemother. 2015 Apr;70(4):1155-60. doi: 10.1093/jac/dku519. Epub 2015 Jan 11. J Antimicrob Chemother. 2015. PMID: 25583751

4

DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan.

Falvella FS, Cheli S, Martinetti A, Mazzali C, Iacovelli R, Maggi C, Gariboldi M, Pierotti MA, Di Bartolomeo M, Sottotetti E, Mennitto R, Bossi I, de Braud F, Clementi E, Pietrantonio F. Falvella FS, et al. Br J Clin Pharmacol. 2015 Sep;80(3):581-8. doi: 10.1111/bcp.12631. Epub 2015 Jun 22. Br J Clin Pharmacol. 2015. PMID: 25782327 Free PMC article.

5

Long-term renal effects of tenofovir-disoproxil-fumarate in vertically HIV-infected children, adolescents, and young adults: a 132-month follow-up study.

Giacomet V, Nannini P, Vigano A, Erba P, Benincaso A, Bedogni G, Cattaneo D, Falvella FS, Zuccotti GV. Giacomet V, et al. Among authors: falvella fs. Clin Drug Investig. 2015 Jul;35(7):419-26. doi: 10.1007/s40261-015-0293-7. Clin Drug Investig. 2015. PMID: 26013475

6

ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors.

Lombardi A, Landonio S, Magni C, Cheli S, Mazzali C, Mondelli MU, Rizzardini G, Clementi E, Falvella FS. Lombardi A, et al. Among authors: falvella fs. Pharmacology. 2015;96(3-4):163-6. doi: 10.1159/000438486. Epub 2015 Aug 8. Pharmacology. 2015. PMID: 26279293

7

The combination of pharmacogenetic and pharmacokinetic analyses to optimize clomipramine dosing in major depression: a case report.

Antoniazzi S, Tatulli A, Falvella FS, Cigliobianco M, Paoli RA, Cattaneo D, Cheli S, Bernardi FF, Clementi E, Altamura CA. Antoniazzi S, et al. Among authors: falvella fs. J Clin Pharm Ther. 2017 Feb;42(1):119-121. doi: 10.1111/jcpt.12478. Epub 2016 Oct 31. J Clin Pharm Ther. 2017. PMID: 27800629

8

Renal function in HIV/HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting.

Milazzo L, Gervasoni C, Falvella FS, Cattaneo D, Mazzali C, Ronzi P, Binda F, Cheli S, Sollima S, Antinori S. Milazzo L, et al. Among authors: falvella fs. Clin Exp Pharmacol Physiol. 2017 Feb;44(2):191-196. doi: 10.1111/1440-1681.12691. Clin Exp Pharmacol Physiol. 2017. PMID: 27809359

9

Pharmacokinetics and Pharmacogenetics of Selective Serotonin Reuptake Inhibitors During Pregnancy: An Observational Study.

Pogliani L, Falvella FS, Cattaneo D, Pileri P, Moscatiello AF, Cheli S, Baldelli S, Fabiano V, Cetin I, Clementi E, Zuccotti G. Pogliani L, et al. Among authors: falvella fs. Ther Drug Monit. 2017 Apr;39(2):197-201. doi: 10.1097/FTD.0000000000000370. Ther Drug Monit. 2017. PMID: 28045861 Free article.

10

Pharmacogenetics-based optimisation of atazanavir treatment: potential role of new genetic predictors.

Falvella FS, Ricci E, Cheli S, Resnati C, Cozzi V, Cattaneo D, Gervasoni C, Clementi E, Galli M, Riva A. Falvella FS, et al. Drug Metab Pers Ther. 2017 May 24;32(2):115-117. doi: 10.1515/dmpt-2017-0006. Drug Metab Pers Ther. 2017. PMID: 28599374 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters